Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus

Horses are commonly vaccinated to protect against pathogens which are responsible for diseases which are endemic within the general horse population, such as equine influenza virus (EIV) and equine herpesvirus-1 (EHV-1), and against a variety of diseases which are less common but which lead to greater morbidity and mortality, such as eastern equine encephalomyelitis virus (EEE) and tetanus. This study consisted of two trials which investigated the antigenicity of commercially available vaccines licensed in the USA to protect against EIV, EHV-1 respiratory disease, EHV-1 abortion, EEE and tetanus in horses. Trial I was conducted to compare serological responses to vaccines produced by three manufacturers against EIV, EHV-1 (respiratory disease), EEE, and tetanus given as multivalent preparations or as multiple vaccine courses. Trial II compared vaccines from two manufacturers licensed to protect against EHV-1 abortion, and measured EHV-1-specific interferon-gamma (IFN-gamma) mRNA production in addition to serological evidence of antigenicity. In Trial I significant differences were found between the antigenicity of different commercial vaccines that should be considered in product selection. It was difficult to identify vaccines that generate significant immune responses to respiratory viruses. The most dramatic differences in vaccine performance occurred in the case of the tetanus antigen. In Trial II both vaccines generated significant antibody responses and showed evidence of EHV-1-specific IFN-gamma mRNA responses. Overall there were wide variations in vaccine response, and the vaccines with the best responses were not produced by a single manufacturer. Differences in vaccine performance may have resulted from differences in antigen load and adjuvant formulation.     

Hypoadrenocorticism in young related Nova Scotia duck tolling retrievers.

Five cases of hypoadrenocorticism in young related Nova Scotia duck tolling retrievers are discussed. Two were littermates and the others shared one or more common ancestors. No specific mode of inheritance was determined. Clinical and laboratory findings typical of hypoadrenocorticism were observed. Further documentation will be required to confirm a breed predisposition.     

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance. Here, we describe a gefitinib-sensitive lung cancer cell line that developed resistance to gefitinib as a result of focal amplification of the MET proto-oncogene. inhibition of MET signaling in these cells restored their sensitivity to gefitinib. MET amplification was detected in 4 of 18 (22%) lung cancer specimens that had developed resistance to gefitinib or erlotinib. We find that amplification of MET causes gefitinib resistance by driving ERBB3 (HER3)-dependent activation of PI3K, a pathway thought to be specific to EGFR/ERBB family receptors. Thus, we propose that MET amplification may promote drug resistance in other ERBB-driven cancers as well.     

Reversal of creatine kinase translational repression by 3' untranslated sequences

A subline of U937 cells (U937D) was obtained in which creatine kinase B (CK-B) messenger RNA was present and bound to ribosomes, but CK activity was undetectable. Transformation of U937D cells with retrovirus vectors that contain the 3' untranslated region (3' UTR) of CK-B messenger RNA exhibited CK activity with no change in abundance of CK-B mRNA. The 3' UTR formed a complex in vitro with a component of S100 extracts from wild-type cells. This binding activity was not detectable in S100 extracts from cells that expressed CK activity after transformation with the 3' UTR-containing vector. These results suggest that translation of CK-B is repressed by binding of a soluble factor or factors to the 3' UTR.     

Changes in albacore tuna habitat in the northeast Pacific Ocean under anthropogenic warming

Albacore tuna are widespread in the North Pacific Ocean and the basis of an important commercial fishery. These fish live mainly within a fairly narrow thermal niche range defined by sea surface temperature (SST) isotherms between 14 and 19°C. Because the fish's thermal range coincides with strong latitudinal temperature gradients off the northwest coast of North America, there is a great deal of seasonal and interannual variability in the distribution of these fish, and a significant potential for a new habitat in this region with anthropogenic climate change. We use historical catch and effort data from the Canadian troll fleet to define the fish's thermal niche, and document observed shifts in distribution associated with interannual climate variability. We then use an ensemble of climate model simulations from the Coupled Model Intercomparison Project to estimate northward extension of the potential habitat under anthropogenic warming scenarios. A potential new habitat is about half a million square kilometres even under a moderate mitigation scenario. Estimates are smaller for some months of the year in which the fishery is conducted, but as well as opening up new regions, the length of season in which the fishery is active may be extended in the northern part of the range. However, much of the potential new habitat will be in oceanic waters with relatively low productivity. Our estimated area of potential habitat is based on the fish's thermal niche and assumes that other biologically important factors such as food will not be limiting.     

Induction of chicken interferon by avian infectious bronchitis virus.

The ability of nine strains of avian infectious bronchitis virus (IBV) to induce chicken interferon has been investigated using Semliki Forest virus for the tests. The Beaudette, H120 and Connecticut 46 strains induced interferon in the allantoic fluids of embryonated hens' eggs, the highest titre (1 : 30) being associated with Beaudette; but these as well as the Massachusetts M-41 and H52 strains failed to yield interferon in primary monolayer cultures of chick kidney cells as did all nine strains in organ cultures of chick embryo trachea. None of six strains of IBV investigated was susceptible to the inhibitory effects of chicken interferon.     

Genomic typing of Streptococcus uberis isolates from cases of mastitis, in New Zealand dairy cows, using pulsed-field gel electrophoresis

Three hundred and forty-two Streptococcus uberis isolates were cultured from milk samples from subclinical and clinical cases of dairy cattle mastitis. The samples were collected from 15 different New Zealand farming regions, including eight specific farms, during field research trials and veterinary diagnostic investigations. Pulsed-field gel electrophoresis was used to determine and compare the degree of genetic dissimilarity between the restriction endonuclease fragment pattern of the 342 New Zealand and a single United States S. uberis isolate. The 343 isolates exhibited 330 different restriction endonuclease fragment patterns. The United States isolate had a pattern unlike any of the New Zealand isolates. Most of the isolates were genetically different strains (pattern deferred by at least 33%), but identical patterns were noted within the same or different quarters of an individual cow, different cows within the same farm, and from different cows from the same or different districts, farming regions or islands. Seven of the eight selected farms had at most only one pair of isolates with banding patterns, which differed by less than 33%. A high degree of dissimilarity was noted in individual herds in which all the samples were collected on the same day or over a 2-year period. The high degree of dissimilar isolates is an indication that S. uberis infections in New Zealand dairy cattle are largely due to the opportunistic nature of the organism in the cows' environment. Prevention and treatment of S. uberis mastitis will therefore need to be directed at a multitude of different strains present throughout the country as well as in individual herds.     

Squamous cell carcinoma in a tuatara (Sphenodon punctatus)

CASE HISTORY: A mature male tuatara was presented with a history of recurrent cloacal prolapse.

CLINICAL AND PATHOLOGICAL FINDINGS: The prolapsed tissue included a 12 mm diameter mass, which histologically showed cords and nodules of neoplastic epithelial cells.

DIAGNOSIS: The mass was diagnosed as a squamous cell carcinoma with ulceration of the overlying stratified squamous epithelium and diffuse inflammation of the surrounding dermis.

CLINICAL RELEVANCE: This case presented a rare opportunity to investigate squamous cell carcinoma in a long-lived lower vertebrate species. Future recurrence or metastasis of the mass may add useful information to the current base of knowledge of the behaviour of malignant neoplasms in reptiles.     

牦牛大肠埃希氏菌病灭活疫苗的制备

用本实验室分离鉴定的致病性牦牛大肠埃希氏菌，按常规方法制备了4批氢氧化铝胶灭活疫苗。对牦牛大肠埃希氏菌的菌液培养、纯粹检验、活菌计数、灭活等进行了探索，并对用该菌研制成的疫苗进行了常规检验。结果4批灭活疫苗经无菌检验为阴性；经物理性状检验为：静置后上层是淡黄色的澄明液体，下层为灰白色沉淀，振荡后呈均匀混浊液；经牦牛安全检验结果为安全；经牦牛效力试验有效。牦牛大肠埃希氏菌病灭活疫苗为免疫预防该病打下了良好的基础。     

A diet formulated from by‐products and indigenous foodstuffs for laying hens

1. The performance of six commercial stocks of laying hens fed on a diet composed of home‐produced foodstuffs, not usually used for human consumption, was compared with that of birds fed on a conventional diet.

2. The experimental diet was calculated to be low in energy and methionine and high in fibre by conventional standards. Birds ate up to 12% more of this diet, but the calculated intakes of energy and methionine were less than those of the corresponding controls.

3. White stocks fed on the experimental diet produced seven eggs less per bird than controls while the production of brown stocks was essentially unaffected.

4. The gross efficiency of energy utilisation for egg production was better with the experimental diet.